Kyverna Therapeutics, Inc. (KYTX) stock
KYTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$4.26−0.11 (-2.52%)
Close on Nov 20, 2026Market cap $263.45MP/E –Yield –
Kyverna Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Kyverna Therapeutics's market cap was $315.24M on Nov 11, 2026, against $335.90M a year earlier. Over the last 3 years it ranged from $18.93M to $540.23M, with a median of $315.24M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $315.24M | -23.4% |
| 2025 | Dec 31, 2025 | $411.66M | +155.0% |
| 2024 | Dec 31, 2024 | $161.45M | – |
See a number that looks wrong?